Research related to fluoroquinolones.
Macrolones, a new class of antibiotics combining macrolides and quinolones, promise to combat bacterial resistance but raise significant concerns about toxicity and long-term health risks.
Based on many years of anecdotal evidence by citizen scientists, and the results of some recent research findings, this paper proposes a theory that, if proven true, would suggest a novel mechanism behind FQAD in an otherwise healthy population in the absence of genetic predispositions.
Pharmaceutical research since 2009 as shown that quinolone molecules are suitable for designing newer derivatives against influenza viruses based upon promising antiviral activity seen.
Could hydrogen sulfide (H2S) be driving some of your chronic floxing symptoms? Evidently it is in a subset of individuals who are chronically floxed.
Dr. Jack Kruse's ideas on the mechanisms of Fluoroquinolone Toxicity. This is an above average read for many, but some great ideas can be gleaned from it.
In this article I refute the smoking gun scenario, discuss why some people seemingly do not have adverse events, reveal why Cipro damages the brain, why they are still on the market, and, again, reiterate just how horribly damaging the FQ’s are to mitochondria.
A follow-up to my muscle biopsy from February 7th, 2017 and subsequent mitochondrial DNA sequencing.
Drug’s that can mutate DNA and create a disease process are downright scary. They start the ball rolling on a pathology that often appears later on..
One culprit that is often overlooked in chronic Fluoroquinolone toxicity is small intestinal bacterial overgrowth, or SIBO.
I believe that metabolomics is going to open a door for giving us insight into chronic fluoroquinolone toxicity and provide insight into treatment options for those chronically suffering.
It is this author’s opinion, that anything based on the quinoline pharmacophore synthetic or not, whose history can be traced all the way back to the cinchona tree, has a unique propensity for toxic damage in the human body.
Dr. Charles Bennett has been able to successfully publish a paper titled "Fluoroquinolone-Related Neuropsychiatric and Mitochondrial Toxicity: a collaborative investigation by scientists and members of a social network."
A interesting two part series covering our five year research relationship with Dr. Noble, U of R; In this article, part 2, he reveals troubling findings about Levaquin.
A interesting two part series covering our five year research relationship with Dr. Noble, U of R; He has assisted us with a submission for the upcoming FDA Meeting, asked us to collect data for his research, and in part 2 reveals troubling findings about Levaquin.
Dr. Beatrice Golomb, University of California San Diego, has been able to successfully publish a paper with four case reports of individuals suffering from Fluoroquinolone Toxicity.
